C-型钠尿肽(CNP)重组蛋白

YB721Ra011
Recombinant C-Type Natriuretic Peptide (CNP)
Organism Species: Homo sapiens (Human)
Instruction manual
FOR IN VITRO USE AND RESEARCH USE ONLY
NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
10th Edition (Revised in Jan, 2014)
C-型钠尿肽(CNP)重组蛋白[ PROPERTIES ]
Residues: Arg33~Gly125
Tags: N-terminal His-Tag
Accession: P23582
Host: E. coli
Subcellular Location: Secreted. Purity: >95%
Endotoxin Level: <1.0EU per 1μg
(determined by the LAL method).
Formulation: Supplied as lyophilized form in 20mM Tris,
150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT,
C-型钠尿肽(CNP)重组蛋白0.01% sarcosyl, 5% trehalose, and preservative.
Predicted isoelectric point: 10.3
Predicted Molecular Mass: 11.3kDa
Accurate Molecular Mass: 16kDa as determined by SDS-PAGE reducing conditions.
Applications: SDS-PAGE; WB; ELISA; IP.
(May be suitable for use in other assays to be determined by the end user.)
Note: The possible reasons that the actual band size differs from the predicted are as follows:
1. Splice variants: Alternative splicing may create different sized proteins from the same gene.
2. Relative charge: The composition of amino acids may affects the charge of the protein.
3. Post-translational modification: Phosphorylation, glycosylation, methylation etc.
4. Post-translation cleavage: Many proteins are synthesized as pro-proteins, and then cleaved to
give the active form.
5. Polymerization of the target protein: Dimerization, multimerization etc.
[ USAGE ]
Reconstitute in sterile ddH2O. [ STORAGE AND STABILITY ]
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8oC for one month.
Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target
protein. The loss rate was determined by accelerated thermal degradation test,
that is, incubate the protein at 37oC for 48h, and no obvious degradation and
C-型钠尿肽(CNP)重组蛋白 5% within the expiration date under appropriate storage condition.
[ SEQUENCES ]
The sequence of the target protein is listed below.
RTPPAEEL AEPQAAGGGQ KKGDKAPGGG GANLKGDRSR LLRDLRVDTK SRAAWARLLQ
EHPNARKYKG ANKKGLSKGC FGLKLDRIGS MSGLG
[ REFERENCES ]
1. Tawaragi Y., et al. (1991) Biochem. Biophys. Res. Commun. 175:645-651.
2. Ogawa Y., et al. (1992) Hypertension 19:809-813.
3. Ishizaka Y., et al. (1992) Biochem. Biophys. Res. Commun. 189:697-704.
4. Koller K.J., et al. (1991) Science 252:120-123.